News Release

Treating hereditary retinal degeneration

Peer-Reviewed Publication

Proceedings of the National Academy of Sciences

Researchers report that administration of a nanosized liposomal formulation containing an analog of the signaling molecule cGMP helped reduce rod photoreceptor loss and restore retinal function in three different rodent models of hereditary retinal degeneration, a neurodegenerative condition that leads to loss of photoreceptors and blindness and that lacks effective treatments.

###

Article #17-18792: "Combination of cGMP analogue and drug delivery system provides functional protection in hereditary retinal degeneration," by Eleonora Vighi et al.

MEDIA CONTACT: Francois Paquet-Durand, University of Tuebingen, GERMANY; tel: +49 7071 29 87430, 0+49 162 238 3255; e-mail: <francois.paquet-durand@klinikum.uni-tuebingen.de>


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.